This user was banned for violating the House Rules. The ban is for social activity only - participating in public chats, publishing ideas, commenting and so on. The ban has no effect on the functionality of the platform.
SPRT near to strong weekly support level. possibly buy. wait for confirmation. I cant believe the Food and Drug Administration rejected the latest Duchenne muscular dystrophy drug, dubbed golodirsen. This could get ugly. Watching for a bounce and keeping an eye on the overall market as well. also watching this one.